The Biologic Development Lifecycle
The Selexis SUREtechnology Platform™ provides users a single platform that can be used for a wide range of applications from late R&D to Biologics Manufacturing
- Target discovery
- Selexis SUREvariant screening™ speeds displayed library screening as well as assessment and selection of lead clinical protein therapeutic candidates
- Cell-based Assays
- The Selexis SUREtechnology Platform™ allows for generation of high quality cell lines for cell based assays used in drug discovery and screening campaigns.
- Protein production for discovery and pre-clinical studies
- Selexis SUREpools™ and SUREclones™ provide a robust and consistent source of protein material for early studies
- Diagnostics
- The Selexis SUREtechnology Platform™ allows for generation of high quality protein reagents for diagnostic applications
- Bio Manufacturing of Therapeutic proteins
- More than 20 Selexis cell lines are in clinical trials up to Phase II
Coming Soon
- Designer cell lines
- The Selexis SUREtechnology Platform™ is being expanded to address a number of the issues associated with difficult-to-express proteins.
- CHO display libraries
- In this next generation use of the Selexis SUREtechnology Platform™, it will be possible to do target identification and discovery using an exclusively mammalian-cell based protein display system.
